These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14662861)

  • 1. Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells.
    Salas M; Eckhardt LA
    J Immunol; 2003 Dec; 171(12):6589-98. PubMed ID: 14662861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique function for carboxyl-terminal domain of Oct-2 in Ig-secreting cells.
    Sharif MN; Radomska HS; Miller DM; Eckhardt LA
    J Immunol; 2001 Oct; 167(8):4421-9. PubMed ID: 11591767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor effects on chromosome constitution of cell hybrids.
    Hines MD; Radomska HS; Eckhardt LA
    Cytogenet Cell Genet; 1998; 83(1-2):64-72. PubMed ID: 9925930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
    Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
    Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All known in vivo functions of the Oct-2 transcription factor require the C-terminal protein domain.
    Corcoran LM; Koentgen F; Dietrich W; Veale M; Humbert PO
    J Immunol; 2004 Mar; 172(5):2962-9. PubMed ID: 14978099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.
    Tang H; Sharp PA
    Immunity; 1999 Nov; 11(5):517-26. PubMed ID: 10591177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
    Sepulveda MA; Emelyanov AV; Birshtein BK
    J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines.
    Schweitzer BL; DeKoter RP
    J Immunol; 2004 Jan; 172(1):144-54. PubMed ID: 14688320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
    Matthias P
    Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors.
    Luo Y; Fujii H; Gerster T; Roeder RG
    Cell; 1992 Oct; 71(2):231-41. PubMed ID: 1423591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B.
    Luo Y; Roeder RG
    Mol Cell Biol; 1995 Aug; 15(8):4115-24. PubMed ID: 7623806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
    Malone CS; Wall R
    J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids.
    Radomska HS; Shen CP; Kadesch T; Eckhardt LA
    Immunity; 1994 Nov; 1(8):623-34. PubMed ID: 7600290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells.
    Schweitzer BL; Huang KJ; Kamath MB; Emelyanov AV; Birshtein BK; DeKoter RP
    J Immunol; 2006 Aug; 177(4):2195-207. PubMed ID: 16887979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the OCA-B promoter.
    Stevens S; Wang L; Roeder RG
    J Immunol; 2000 Jun; 164(12):6372-9. PubMed ID: 10843692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
    Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
    Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.
    Qin XF; Reichlin A; Luo Y; Roeder RG; Nussenzweig MC
    EMBO J; 1998 Sep; 17(17):5066-75. PubMed ID: 9724642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes.
    Kim U; Qin XF; Gong S; Stevens S; Luo Y; Nussenzweig M; Roeder RG
    Nature; 1996 Oct; 383(6600):542-7. PubMed ID: 8849728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of OCA-B in 3'-IgH enhancer function.
    Stevens S; Ong J; Kim U; Eckhardt LA; Roeder RG
    J Immunol; 2000 May; 164(10):5306-12. PubMed ID: 10799892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.